ArticleBreast cancer research : BCR2018

Circulating ESR1 mutations at the end of aromatase inhibitor adjuvant treatment and after relapse in breast cancer patients.

Violette Allouchery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.